27 Phase III and 8 Phase II Alzheimer's drugs on track to launch in next five years
Twenty-seven Alzheimer's drugs in Phase III clinical trials and eight drugs in Phase II clinical trials may launch in the next five years, according to a revised Alzheimer's pipeline analysis presented today at the Alzheimer's ...
Jul 18, 2017
0
11